The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients
- 279 Downloads
Fibrinogen plays an important role in the pathophysiology of tumour cell invasion and metastases. In recent studies, an elevated plasma fibrinogen level has been associated with poor prognosis in different types of cancer. The present study was performed to analyse the prognostic impact of an elevated fibrinogen level in prostate cancer patients.
We evaluated data from 268 prostate cancer patients who underwent 3D conformal radiotherapy between 1999 and 2006 at a single tertiary academic center. Cancer-specific survival (CSS), overall survival (OS), and clinical disease-free survival (DFS) were assessed using the Kaplan–Meier method. Univariable and multivariable Cox regression models were performed for each endpoint.
Applying receiver operating characteristics (ROC) curve analysis, the optimal cut-off level for the plasma fibrinogen level was 530 mg dl−1, respectively. Univariable (HR 3.638, 95 % CI 1.15–11.47, p = 0.027) and multivariable analyses (HR 3.964, 95 % CI 1.06–14.87, p = 0.041) revealed a significant correlation between increased plasma fibrinogen and CSS. Univariable analysis also showed a significant association between the elevated plasma fibrinogen level and decreased OS (HR 3.242, 95 % CI 1.53–6.89, p = 0.002), that remained significant in multivariable analysis (HR 3.215, 95 % CI 1.44–7.19, p = 0.004). No significant associations were found for clinical DFS.
Although our data show a significant association between an elevated plasma fibrinogen level and poor prostate cancer prognosis, they have to be interpreted cautiously. Limitations of the present study are caused by its retrospective design, the limited accuracy obtained using ROC curve analysis, and potential confounding factors like cardiovascular disease and inflammatory diseases that have not been accounted for.
KeywordsProstate cancer Radiotherapy Prognosis Coagulation Fibrinogen
Conflict of interest
The authors declare that they have no conflict of interest.
The study complied with the Declaration of Helsinki and has been approved by the local Ethical Committee.
- 10.Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, Kubochi K, Kitajima M, Matsumoto S (2007) Pretreatment plasma fibrinogen level correlates with tumour progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol 22:2222–2227CrossRefPubMedGoogle Scholar
- 17.Pichler M, Hutterer GC, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R (2013) High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer 109:1123–1129. doi: 10.1038/bjc.2013.443 PubMedCentralCrossRefPubMedGoogle Scholar
- 18.Pichler M, Dalpiaz O, Ehrlich GC, Stojakovic T, Martín Hernández JM, Mannweiler S, Pummer K, Zigeuner R, Hutterer GC (2013) Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma. J Urol 191:920–925. doi: 10.1016/j.juro.2013.10.073 CrossRefPubMedGoogle Scholar
- 20.Steinbrecher KA, Horowitz NA, Blevins EA, Barney KA, Shaw MA, Harmel-Laws E, Finkelman FD, Flick MJ, Pinkerton MD, Talmage KE, Kombrinck KW, Witte DP, Palumbo JS (2010) Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res 70:2634–2643. doi: 10.1158/0008-5472.CAN-09-3465 PubMedCentralCrossRefPubMedGoogle Scholar
- 23.McDonald AC, Vira MA, Vidal AC, Gan W, Freedland SJ, Taioli E (2014) Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease—the 2001–2008 National Health and Nutrition Examination Survey. Prostate 74:561–567. doi: 10.1002/pros.22782 PubMedCentralCrossRefPubMedGoogle Scholar
- 24.Tiedje V, Dunkler D, Ay C, Horvath B, Quehenberger P, Pabinger M, Zielinski C, Pabinger I, Mannhalter C (2011) The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis. Thromb Haemost 106:908–913. doi: 10.1160/TH11-04-0278 CrossRefPubMedGoogle Scholar